What is a pessary device, its indications, insertion technique, follow-up care, and potential complications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pessary Device Overview

A pessary is a removable vaginal device used primarily for two distinct purposes: (1) supporting pelvic organs in women with pelvic organ prolapse (POP), and (2) attempting to prevent preterm birth in pregnant women with cervical shortening, though the latter remains controversial and should only be used in research settings.

What is a Pessary?

A pessary is a silicone or plastic device inserted into the vagina to provide mechanical support. The specific design varies based on indication:

  • For pelvic organ prolapse: Multiple types exist (ring, Gellhorn, cube, donut) designed to support descending vaginal compartments 1, 2
  • For pregnancy (Arabin pessary): A ring-shaped silicone device that encircles the cervix, theoretically altering the uterocervical angle to redirect gravitational forces away from the internal os 3, 4

Indications

For Pelvic Organ Prolapse (Non-Pregnant Women)

  • Symptomatic pelvic organ prolapse when surgery is not desired or contraindicated
  • As a diagnostic tool to predict surgical outcomes
  • First-line conservative management option 2, 5

For Preterm Birth Prevention (Pregnant Women)

Critical caveat: The evidence for cervical pessary in pregnancy is highly conflicting, and current guidelines are restrictive.

The Society for Maternal-Fetal Medicine explicitly recommends that cervical pessary placement in pregnancy to decrease preterm birth be used ONLY in the context of a clinical trial or research protocol 3. This is because:

  • The Arabin pessary is not FDA-approved for preterm birth prevention in the United States 3
  • Multiple large randomized trials show contradictory results 3, 4
  • One Spanish trial showed dramatic 82% reduction in preterm birth 4, but a large multinational trial showed no benefit 4
  • The 2024 SMFM guidelines do not provide a clear recommendation for or against pessary use even in research contexts, reflecting ongoing uncertainty 4

Insertion Technique

For Pelvic Organ Prolapse

  • Selection requires trial and error fitting, as evidence for specific selection criteria is incomplete 2
  • Proper fit is essential for effectiveness and determined through clinical trial 6
  • The device should be comfortable, reduce prolapse symptoms, and allow for normal voiding and defecation 1
  • Patients can often be taught self-insertion and removal 1, 7

For Cervical Pessary (Research Setting Only)

  • Typically placed between 18-24 weeks of gestation in research protocols 3, 4
  • The Arabin pessary encircles the cervix with its caudal portion 3
  • Insertion is relatively straightforward with low technical difficulty 3

Follow-Up Care

For Pelvic Organ Prolapse

The 2023 American Urogynecologic Society consensus reached agreement on follow-up protocols 1:

  • Initial follow-up typically within 1-2 weeks after fitting
  • Routine maintenance visits vary based on patient's ability to self-manage
  • Patients capable of self-care can have less frequent clinic visits 1, 8
  • Self-management is cost-effective and enhances patient autonomy 8

For Cervical Pessary (Research Setting)

  • In research protocols, pessaries typically remain until 37 weeks of gestation 3
  • Approximately 11% require early removal before 34 weeks 3
  • Regular assessment for complications is necessary

Potential Complications

For Pelvic Organ Prolapse

Common but generally manageable complications include:

  • Vaginal discharge (most common)
  • Vaginal erosion and bleeding
  • Discomfort
  • Urinary tract infections
  • Rare serious complications: fistula formation, impaction 1, 7, 5

For Cervical Pessary in Pregnancy

The Arabin pessary appears to have low rates of major complications 3:

  • Increased vaginal discharge: Most common side effect, with 15-20% requiring medical evaluation to exclude infection or membrane rupture 3
  • All participants in one trial reported increased vaginal discharge 4
  • Actual vaginal infection rates: Similar between pessary and control groups in RCTs 3
  • Discomfort: Reported with placement and removal 3
  • Repositioning needed: 14% of patients in one trial 4
  • Serious adverse events (cervical ischemia): Rare 3
  • Unknown long-term effects: Whether pessary alters vaginal microbiome with impact on maternal/neonatal outcomes remains unknown 3

Critical Clinical Pitfalls

  1. Do not use cervical pessary for preterm birth prevention outside of research protocols - this is explicit guideline recommendation despite some positive trials 3

  2. For prolapse pessaries: Improper fit, inadequate patient education, and lack of self-management training contribute to discontinuation 8

  3. Vaginal discharge with cervical pessary requires evaluation - while infection rates are not increased, the high rate of discharge (15-20%) necessitating evaluation means clinicians must maintain vigilance 3

  4. The evidence for cervical pessary remains inconclusive even with multiple large trials, highlighting the importance of not adopting interventions before adequate testing 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.